Barbara Haigl

414 citations
10 papers · 324 indexed · h-index 8
Topics
Fibroblast Growth Factor Research (4 papers)Epigenetics and DNA Methylation (3 papers)Orthopaedic implants and arthroplasty (2 papers)
Partner nations
AustriaSwedenGermany

In The Last Decade

Barbara Haigl

10 papers receiving 320 citations

Peers

Barbara Haigl
Comparison fields: 5 of 64
  • Molecular Biology 231
  • Cancer Research 81
  • Oncology 80
  • Orthopedics and Sports Medicine 64
  • Genetics 44
Replace Raúl Javier García-Renedo with:
Raúl Javier García-Renedo Spain
Mitsuyasu Iwasawa Japan
Kyung‐Eun Lim South Korea
José Antonio Valer Spain
Zenong Yuan China
Lunqing Zhu China
Peter Paruzel Germany
Vicente Meliton United States
DW Dempster United States
Keita Nagira Japan
Barbara Haigl relative to Raúl Javier García-Renedo Spain Raúl Javier García-Renedo's profile →
Citations per field
00.5×3.5×
Raúl Javier García-Renedo · 1×
Citations per year

Countries citing papers authored by Barbara Haigl

Since Specialization
Citations

This map shows the geographic impact of Barbara Haigl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Haigl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Haigl more than expected).

Fields of papers citing papers by Barbara Haigl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Haigl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Haigl. The network helps show where Barbara Haigl may publish in the future.

Co-authorship network of co-authors of Barbara Haigl

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Haigl. A scholar is included among the top collaborators of Barbara Haigl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Haigl. Barbara Haigl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 11
2 5
3 3
4 175
5 49
6 10
7 10
8 22
9 22
10 17

About Barbara Haigl

Barbara Haigl is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 10 papers that have together received 324 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (4 papers), Epigenetics and DNA Methylation (3 papers) and Orthopaedic implants and arthroplasty (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (64 citations), Cancer Research (81 citations) and Molecular Biology (231 citations). Barbara Haigl has collaborated with scholars based in Austria, Sweden and Germany. Frequent co-authors include Hedwig Sutterlüty, Reinhold G. Erben, Christiane Schüler, Karoline Kollmann, Veronika Sexl, Carmen Streicher, Miriam Kleiter, Olena Andrukhova, Paul J. Kostenuik and Lorenz C. Hofbauer. Their work appears in journals such as PLoS ONE, Scientific Reports and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026